Search results for: 'purotoxin 1'
-
BA7998 LeramistatSummary: Leramistat (HMC-C-01-A; MBS2320) is an inhibitor of mitochondrial complex 1 and is involved in the regulation of cellular metabolism immunometabolism. - BA5221 OMDM-6Summary: OMDM-6 is a mixed agonist of the receptor (=75 nM) and cannabinoid type 1 receptor (=3.2 μM).
- BA5446 GemilukastSummary: Gemilukast is an orally active, potent dual inhibitor of cysteinyl leukotriene 1 and 2 receptors (and).
- BA5467 ASP-4058Summary: ASP-4058 is a selective, orally active, second generation agonist of sphingosine phosphate receptors 1 and 5.
- BA6784 BAY-8002Summary: BAY-8002 is a potent, selective, orally available inhibitor of monocarboxylic acid transporter protein subtype 1.
- BA3112 M47Summary: M47 is a small molecule that selectively destabilizes cryptorchidin 1 (CRY1) and increases the degradation of CRY1 in the nucleus.
- BA3504 PK68Summary: PK68 is a potent and specific type II inhibitor of receptor-interacting kinase 1 (RIPK1) with oral activity.
- BA4978 GivosiranSummary: Givosiran (ALN-AS1) is a small interfering RNA that targets hepatic aminocellulose synthase 1 messenger RNA.
-
R1101 EZ Cap™ BFP mRNA (m1Ψ)Summary: Blue fluorescent protein (BFP) mRNA with Cap 1 structure, modified by N1-Methylpseudo-UTP (m1Ψ), providing higher transcription efficiency and suppressing RNA-mediated innate immune activation. -
R1103 EZ Cap™ mOrange mRNA (m1Ψ)Summary: Orange Fluorescent Protein (mOrange) mRNA with Cap 1 structure, modified by N1-Methylpseudo-UTP (m1Ψ), providing higher transcription efficiency and suppressing RNA-mediated innate immune activation.